160 Health International Limited (160 Health) filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming stable share capital and compliance with Hong Kong Stock Exchange (HKEX) requirements.

Authorised Share Capital • Authorised ordinary shares remained unchanged at 25.00 billion, each with a par value of USD 0.000002, keeping total authorised capital at USD 50,000.

Issued and Treasury Shares • Issued shares (excluding treasury shares) stood at 336.45 million, with zero treasury shares outstanding. • No issuance, cancellation, repurchase, or transfer of shares occurred during the month, leaving total issued share capital unchanged.

Public Float Compliance • 160 Health confirmed adherence to HKEX Main Board Rule 13.32D(1), maintaining at least the 25 % minimum public float requirement as of 31 May 2026.

Share Option Activity • Under the Pre-IPO Share Option Scheme effective 31 August 2023, 31.18 million options remained outstanding, covering 14.49 million new shares and 16.70 million existing shares. • No options were exercised, and no funds were raised during the month.

Other Equity Instruments • The company reported no warrants, convertible securities, or other share-issuance arrangements in May.

Regulatory Confirmations • The filing affirms that all statutory and listing obligations—including receipt of consideration for any securities issued, fulfilment of listing conditions, and filing of required documents—have been satisfied.

Overall, 160 Health’s capital structure and share count were unchanged in May 2026, and the company sustained full compliance with HKEX public float requirements.